A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
Diseases of the Nervous System | Immune System
What is the purpose of this trial?
This study is a multi center, open-label, study of ANX005 in combination with IVIg in subjects diagnosed with GBS.
- Ages18 years and older
- Trial withAnnexon, Inc.
- Start Date10/15/2019
- End Date09/29/2020
- Last Updated02/07/2020
- Study HIC#2000025922